Report cover image

Global Exosome Research Products Market Size Study, by Service (Kits, Reagents [Antibodies, Isolation Purification], Instruments), by Indication (Cancer, Infectious Diseases), by Application (Biomarkers, Vaccines), by Manufacturing Services (Stem Cell), a

Publisher Factview Research
Published Jun 27, 2025
Length 285 Pages
SKU # FAVR20179343

Description

The Global Exosome Research Products Market, valued at approximately USD 177.5million in 2024, is poised for significant growth, with an estimated compound annual growth rate (CAGR) of 16.4% from 2024 to 2034. Exosomes, extracellular vesicles secreted by various cells, have emerged as critical players in intercellular communication and biological research. These tiny vesicles are instrumental in the development of diagnostics, therapeutics, and drug delivery systems, owing to their ability to carry molecular cargo, including RNA, DNA, and proteins. The burgeoning focus on precision medicine and innovative drug development has catalyzed the demand for exosome research products globally.

The expanding application of exosomes as biomarkers and their role in vaccine development are notable drivers for the market's growth trajectory. Kits and reagents, particularly those for isolation and purification, are experiencing heightened demand as researchers strive to streamline workflows and improve accuracy. Moreover, the integration of exosome-based approaches in cancer diagnosis and infectious disease management underscores the field’s versatility. However, challenges such as standardization of isolation techniques and high costs associated with advanced instruments may impede growth. Nonetheless, advancements in manufacturing services, particularly stem cell-derived exosome production, offer lucrative opportunities for market players.

Regionally, the exosome research products market exhibits diverse growth patterns. North America leads, driven by a robust research infrastructure, substantial investment in biotechnology, and the presence of key market players. Europe follows closely, benefiting from regulatory support and collaborative research initiatives. Meanwhile, the Asia-Pacific region is witnessing rapid growth, fueled by increasing healthcare investments, a growing focus on precision medicine, and the expanding presence of research organizations in countries like China, Japan, and India. Emerging markets in Latin America and the Middle East & Africa are also gaining traction, driven by rising interest in advanced diagnostics and therapeutics.

The exosome research products market is set to undergo a transformative phase as industry participants focus on innovation, partnerships, and expanding product portfolios. Companies are leveraging advancements in bioengineering and nanotechnology to enhance the scalability and efficiency of exosome isolation and application. The shift towards customized exosome solutions, coupled with an emphasis on sustainability and cost-effective production, will likely shape the market's future dynamics.

Major market players included in this report are:
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • System Biosciences, LLC
  • Bio-Techne Corporation
  • Miltenyi Biotec
  • NanoView Biosciences
  • Lonza Group Ltd.
  • Creative Biolabs
  • Norgen Biotek Corp.
  • Exosome Diagnostics, Inc. (A Bio-Techne Brand)
  • AMSBIO
  • Codiak BioSciences
  • Evomic Science LLC
  • Cell Guidance Systems
  • Capricor Therapeutics
The detailed segments and sub-segments of the market are explained below:

By Service:
  • Kits
  • Reagents
Antibodies

Isolation Purification
  • Instruments
By Indication:
  • Cancer
  • Infectious Diseases
By Application:
  • Biomarkers
  • Vaccines
By Manufacturing Services:
  • Stem Cell
By Region:

North America:
  • U.S.
  • Canada
Europe:
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia-Pacific:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific
Latin America:
  • Brazil
  • Mexico
  • Rest of Latin America
Middle East & Africa:
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
Years considered for the study are as follows:
  • Historical Year: 2022
  • Base Year: 2024
  • Forecast Period: 2024 to 2034
Key Takeaways:
  • Market estimates and forecasts for 10 years from 2022 to 2032.
  • Annualized revenues and regional-level analysis for each market segment.
  • Comprehensive geographical insights with country-level analysis for major regions.
  • Competitive landscape profiling major market players and their strategic initiatives.
  • Analysis of key business strategies and recommendations for future market approaches.

Table of Contents

285 Pages
Chapter 1. Global Exosome Research Products Market Executive Summary
1.1. Global Exosome Research Products Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Service
1.3.1.1. Kits
1.3.1.2. Reagents
1.3.1.2.1. Antibodies
1.3.1.2.2. Isolation Purification
1.3.1.3. Instruments
1.3.2. By Indication
1.3.2.1. Cancer
1.3.2.2. Infectious Diseases
1.3.3. By Application
1.3.3.1. Biomarkers
1.3.3.2. Vaccines
1.3.4. By Manufacturing Services
1.3.4.1. Stem Cell
1.4. Key Trends
1.5. Recession Impact
1.6. Investment Analysis
1.7. Investment Rationale
1.8. Analyst Recommendation & Conclusion
Chapter 2. Global Exosome Research Products Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Exosome Research Products Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Consumer Awareness and Health Consciousness
3.1.2. Rising Demand for Precision Medicine and Innovative Drug Development
3.1.3. Advancements in Ingredient Innovation and Targeted Delivery Systems
3.2. Market Challenges
3.2.1. Standardization of Isolation Techniques
3.2.2. High Costs Associated with Advanced Instruments
3.3. Market Opportunities
3.3.1. Advancements in Manufacturing Services (Stem Cell-Derived Exosome Production)
3.3.2. Technological Integration (Bioengineering and Nanotechnology)
3.3.3. Strategic Collaborations and Research Initiatives
Chapter 4. Global Exosome Research Products Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Exosome Research Products Market Size & Forecasts by Service 2024-2034
5.1. Segment Dashboard
5.2. Global Exosome Research Products Market: Service Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Kits
5.2.2. Reagents
5.2.2.1. Antibodies
5.2.2.2. Isolation Purification
5.2.3. Instruments
Chapter 6. Global Exosome Research Products Market Size & Forecasts by Indication 2024-2034
6.1. Segment Dashboard
6.2. Global Exosome Research Products Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Cancer
6.2.2. Infectious Diseases
Chapter 7. Global Exosome Research Products Market Size & Forecasts by Application 2024-2034
7.1. Segment Dashboard
7.2. Global Exosome Research Products Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. Biomarkers
7.2.2. Vaccines
Chapter 8. Global Exosome Research Products Market Size & Forecasts by Manufacturing Services 2024-2034
8.1. Segment Dashboard
8.2. Global Exosome Research Products Market: Manufacturing Services Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
8.2.1. Stem Cell
Chapter 9. Global Exosome Research Products Market Size & Forecasts by Region 2024-2034
9.1. North America Exosome Research Products Market
9.1.1. U.S. Exosome Research Products Market
9.1.1.1. Service Breakdown Size & Forecasts, 2024-2034
9.1.1.2. Indication Breakdown Size & Forecasts, 2024-2034
9.1.2. Canada Exosome Research Products Market
9.1.2.1. Service Breakdown Size & Forecasts, 2024-2034
9.1.2.2. Indication Breakdown Size & Forecasts, 2024-2034
9.2. Europe Exosome Research Products Market
9.2.1. UK Exosome Research Products Market
9.2.2. Germany Exosome Research Products Market
9.2.3. France Exosome Research Products Market
9.2.4. Spain Exosome Research Products Market
9.2.5. Italy Exosome Research Products Market
9.2.6. Rest of Europe Exosome Research Products Market
9.3. Asia-Pacific Exosome Research Products Market
9.3.1. China Exosome Research Products Market
9.3.2. India Exosome Research Products Market
9.3.3. Japan Exosome Research Products Market
9.3.4. Australia Exosome Research Products Market
9.3.5. South Korea Exosome Research Products Market
9.3.6. Rest of Asia-Pacific Exosome Research Products Market
9.4. Latin America Exosome Research Products Market
9.4.1. Brazil Exosome Research Products Market
9.4.2. Mexico Exosome Research Products Market
9.4.3. Rest of Latin America Exosome Research Products Market
9.5. Middle East & Africa Exosome Research Products Market
9.5.1. Saudi Arabia Exosome Research Products Market
9.5.2. South Africa Exosome Research Products Market
9.5.3. Rest of Middle East & Africa Exosome Research Products Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Thermo Fisher Scientific, Inc.
10.1.2. Qiagen N.V.
10.1.3. System Biosciences, LLC
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Thermo Fisher Scientific, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Qiagen N.V.
10.3.3. System Biosciences, LLC
10.3.4. Bio-Techne Corporation
10.3.5. Miltenyi Biotec
10.3.6. NanoView Biosciences
10.3.7. Lonza Group Ltd.
10.3.8. Creative Biolabs
10.3.9. Norgen Biotek Corp.
10.3.10. Exosome Diagnostics, Inc. (A Bio-Techne Brand)
10.3.11. AMSBIO
10.3.12. Codiak BioSciences
10.3.13. Evomic Science LLC
10.3.14. Cell Guidance Systems
10.3.15. Capricor Therapeutics
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us